Clinuvel Pharmaceuticals
CUV.AX
#8115
Rank
S$0.48 B
Marketcap
S$9.63
Share price
2.71%
Change (1 day)
-12.19%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: S$43.04 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$62.5 Million. In 2025 the company made an earning of S$43.04 Million, an increase over its 2024 earnings that were of S$42.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025S$43.04 M0.26%
2024S$42.93 M11.35%
2023S$38.55 M28.31%
2022S$30.04 M22.8%
2021S$24.47 M112.63%
2020S$11.5 M-28.73%
2019S$16.14 M32.79%
2018S$12.16 M75.41%
2017S$6.93 M-332.52%
2016-S$2.99 Million-70.68%
2015-S$10.18 Million53.78%
2014-S$6.62 Million-16.1%
2013-S$7.89 Million-37.92%
2012-S$12.7 Million-18.19%
2011-S$15.53 Million25.31%
2010-S$12.39 Million-21.53%
2009-S$15.79 Million-11.27%
2008-S$17.8 Million80.4%
2007-S$9.87 Million-2.46%
2006-S$10.12 Million-5.35%
2005-S$10.69 Million60.55%
2004-S$6.66 Million97.37%
2003-S$3.38 Million50.62%
2002-S$2.24 Million121.22%
2001-S$1.02 Million254.48%
2000-S$0.29 Million